<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00380263</url>
  </required_header>
  <id_info>
    <org_study_id>KA-20060087</org_study_id>
    <nct_id>NCT00380263</nct_id>
  </id_info>
  <brief_title>PACAP38Â´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow</brief_title>
  <official_title>Basic Scientific Research Investigating PACAP38 Headache Inducing Effects in Migraine Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate headache score and accompanying symptoms during and after infusion of PACAP38
      i migraine patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate headache score and accompanying symptoms during and after infusion of PACAP38

      Changes in regional cerebral blood flow (rCBF) in the area supplied by middle cerebral artery
      (MCA), blood flow in MCA, diameter of the superficial temporal artery (STA) and radial artery
      (RA)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">12</enrollment>
  <condition>Migraine Without Aura</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PACAP38</intervention_name>
    <description>10 pmol/kg/min given one time</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy migraine patient without aura

          -  Aged 18-50

          -  50-100 kg

          -  Fertile women must use safe contraceptives (IUD, oral contraceptives, surgical
             sterilisation and long lasting gestagen.

        Exclusion Criteria:

          -  Tension type headache more than five times/month

          -  Other primary headaches

          -  Daily medication except contraceptives

          -  Drug taken within 4 times the halflife for the specific drug except contraceptives

          -  Pregnant or lactating women

          -  Exposure to radiation within the last year

          -  Headache within the last 48 hours before start of trial

          -  Hypertension

          -  Hypotension

          -  Respiratory or cardiac disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik Schytz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danish Headache Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dansih Headache Center</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2006</study_first_submitted>
  <study_first_submitted_qc>September 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2006</study_first_posted>
  <last_update_submitted>May 29, 2008</last_update_submitted>
  <last_update_submitted_qc>May 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2008</last_update_posted>
  <responsible_party>
    <name_title>Henrik Schytz/MD</name_title>
    <organization>Danish Headache Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
    <mesh_term>Migraine without Aura</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pituitary Adenylate Cyclase-Activating Polypeptide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

